Ramalingam Bethunaickan Selected Research

Ramalingam Bethunaickan Research Topics

Disease

10	Tuberculosis (Tuberculoses) 01/2023 - 01/2007
8	Nephritis 01/2021 - 02/2008
6	Infections 04/2024 - 01/2017
6	Pulmonary Tuberculosis 01/2023 - 01/2007
6	Inflammation (Inflammations) 01/2023 - 09/2008
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2015 - 02/2008
4	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2023 - 12/2019
4	Lupus Nephritis 12/2015 - 08/2011
3	Disease Progression 01/2023 - 01/2018
3	Proteinuria 11/2012 - 02/2008
2	Latent Infection 01/2023 - 01/2021
1	Chronobiology Disorders (Circadian Rhythm Disorder) 01/2021
1	Disease Resistance 01/2021
1	Lymphadenitis (Adenitis) 11/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 11/2020
1	Starvation 11/2020
1	Neoplasms (Cancer) 11/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Acute Lung Injury 01/2019
1	HIV Infections (HIV Infection) 01/2018
1	Asymptomatic Diseases 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2014
1	Rheumatoid Arthritis 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Thrombosis (Thrombus) 09/2008
1	Myocardial Infarction 09/2008
1	Glomerulonephritis 02/2008

Drug/Important Bio-Agent (IBA)

9	CytokinesIBA 01/2023 - 02/2008
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2007
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2021
5	Immunoglobulin G (IgG)IBA 01/2013 - 01/2007
5	AutoantibodiesIBA 11/2012 - 09/2008
3	ChemokinesIBA 01/2023 - 02/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2008
3	Antigen-Antibody Complex (Immune Complex)IBA 10/2012 - 02/2008
2	Vitamin D FDA LinkGeneric 01/2023 - 11/2020
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2021
2	EnzymesIBA 11/2020 - 01/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2012
2	InterferonsIBA 10/2012 - 01/2011
2	AntigensIBA 12/2011 - 04/2008
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	LipopolysaccharidesIBA 11/2020
1	Beclin-1IBA 11/2020
1	Pattern Recognition ReceptorsIBA 11/2020
1	Cholecalciferol (Vitamin D3)FDA Link 11/2020
1	OPC-67683IBA 12/2019
1	Moxifloxacin (Avelox)FDA Link 12/2019
1	resazurinIBA 12/2019
1	bedaquiline (R207910)IBA 12/2019
1	Tannic Acid FDA Link 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	NitritesIBA 06/2014
1	ArginaseIBA 06/2014
1	Chemokine ReceptorsIBA 01/2013
1	Glycoproteins (Glycoprotein)IBA 01/2013
1	Cardiolipins (Cardiolipin)IBA 11/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012
1	Therapeutic UsesIBA 10/2012
1	Abatacept (Orencia)FDA Link 08/2011
1	CathepsinsIBA 04/2011
1	Matrix Metalloproteinases (MMPs)IBA 04/2011
1	TACI receptor-IgG Fc fragment fusion proteinIBA 05/2010
1	Inflammation MediatorsIBA 09/2008
1	Mycobacterium tuberculosis antigensIBA 04/2008
1	AntibodiesIBA 04/2008
1	Immunoglobulin A (IgA)IBA 01/2007
1	Immunoglobulin M (IgM)IBA 01/2007
1	ImmunosorbentsIBA 01/2007

Therapy/Procedure

13	Therapeutics 01/2023 - 02/2008
4	Remission Induction 01/2021 - 02/2008